20/20 in 2020: seeking clarity on the management of stage III melanoma in a rapidly changing treatment environment

Por Chandrasekaran, Sanjay, Lawson, David H.
Publicado no Ann Transl Med (2020)

Insights into the Psychology of Trauma Should Inform the Practice of Oncology

Por Lawson, Kathryn C., Lawson, David H.
Publicado no Oncologist (2018)

High Th17:Treg ratio may predict complete response to HDIL-2 in the setting of melanoma

Por Diller, Maggie L, Mandy, Ford, Delman, Keith A, Lawson, David H
Publicado no J Immunother Cancer (2015)

BRAF inhibitors and radiotherapy for melanoma brain metastases: potential advantages and disadvantages of combination therapy

Por Chowdhary, Mudit, Patel, Kirtesh R, Danish, Hasan H, Lawson, David H, Khan, Mohammad K
Publicado no Onco Targets Ther (2016)

Brief Communication: Vogt-Koyanagi-Harada-like Syndrome Following CTLA-4 Inhibition with Ipilimumab for Metastatic Melanoma

Por Crosson, Jason N., Laird, Philip W., Debiec, Matthew, Bergstrom, Chris S., Lawson, David H., Yeh, Steven
Publicado no J Immunother (2015)

Balancing Inflammation: The Link between Th17 and Regulatory T Cells

Por Diller, Maggie L., Kudchadkar, Ragini R., Delman, Keith A., Lawson, David H., Ford, Mandy L.
Publicado no Mediators Inflamm (2016)

Exogenous IL-2 induces FoxP3(+) Th17 cells in vivo in melanoma patients

Por Diller, Maggie L., Kudchadkar, Ragini R., Delman, Keith A., Lawson, David H., Ford, Mandy L.
Publicado no J Immunother (2016)

Complete response to high dose IL-2 (HDIL-2) and enhanced IFNγ(+)Th17:T(REG) ratio in a melanoma patient

Por Diller, Maggie L., Kudchadkar, Ragini R., Delman, Keith A., Lawson, David H., Ford, Mandy L.
Publicado no Melanoma Res (2016)

Radiologic and Histopathologic Correlation of Different Growth Patterns of Metastatic Uveal Melanoma to the Liver: MRI/Pathology of Metastatic UM

Por Liao, Albert, Mittal, Pardeep, Lawson, David H., Yang, Jenny J., Szalai, Eszter, Grossniklaus, Hans E.
Publicado no Ophthalmology (2017)

Rising Incidence of Mucosal Melanoma of the Head and Neck in the United States

Por Marcus, David M., Marcus, Rebecca P., Prabhu, Roshan S., Owonikoko, Taofeek K., Lawson, David H., Switchenko, Jeffrey, Beitler, Jonathan J.
Publicado em 2012

Reduction of Nodular Growth Pattern of Metastatic Uveal Melanoma after Radioembolization of Hepatic Metastases

Por Halenda, Kevin M., Kudchadkar, Ragini R., Lawson, David H., Kies, Darren D., Zhelnin, Kristen E., Krasinskas, Alyssa M., Grossniklaus, Hans E.
Publicado no Ocul Oncol Pathol (2016)

BRAF inhibitor and stereotactic radiosurgery is associated with an increased risk of radiation necrosis

Por Patel, Kirtesh R., Chowdhary, Mudit, Switchenko, Jeffrey M., Kudchadkar, Ragini, Lawson, David H., Cassidy, Richard J., Prabhu, Roshan S., Khan, Mohammad K.
Publicado no Melanoma Res (2016)

Exosome-Containing Preparations From Postirradiated Mouse Melanoma Cells Delay Melanoma Growth In Vivo by a Natural Killer Cell—Dependent Mechanism

Por Jella, Kishore Kumar, Nasti, Tahseen H., Li, Zhentian, Lawson, David H., Switchenko, Jeffrey M., Ahmed, Rafi, Dynan, William S., Khan, Mohammad K.
Publicado no Int J Radiat Oncol Biol Phys (2020)

Roles of adjuvant and salvage radiotherapy for desmoplastic melanoma

Por Oliver, Daniel E., Patel, Kirtesh R., Switchenko, Jeffrey, Parker, Douglas, Lawson, David H., Delman, Keith A., Kudchadkar, Ragini R., Khan, Mohammad K.
Publicado no Melanoma Res (2016)

Two heads better than one? Ipilimumab immunotherapy and radiation therapy for melanoma brain metastases

Por Patel, Kirtesh R., Lawson, David H., Kudchadkar, Ragini R., Carthon, Bradley C., Oliver, Daniel E., Okwan-Duodu, Derick, Ahmed, Rafi, Khan, Mohammad K.
Publicado no Neuro Oncol (2015)

The influence of postoperative lymph node radiation therapy on overall survival of patients with stage III melanoma, a National Cancer Database analysis

Por Danish, Hasan H., Patel, Kirtesh R., Switchenko, Jeffrey M., Gillespie, Theresa W., Jhaveri, Jaymin, Chowdhary, Mudit, Abugideiri, Mustafa, Delman, Keith A., Lawson, David H., Khan, Mohammad K.
Publicado no Melanoma Res (2016)

Phase II study of vemurafenib followed by ipilimumab in patients with previously untreated BRAF-mutated metastatic melanoma

Por Amin, Asim, Lawson, David H., Salama, April K.S., Koon, Henry B., Guthrie, Troy, Thomas, Sajeve S., O’Day, Steven J., Shaheen, Montaser F., Zhang, Bin, Francis, Stephen, Hodi, F. Stephen
Publicado no J Immunother Cancer (2016)

Randomized, Placebo-Controlled, Phase III Trial of Yeast-Derived Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF) Versus Peptide Vaccination Versus GM-CSF Plus Peptide Vac...

Por Lawson, David H., Lee, Sandra, Zhao, Fengmin, Tarhini, Ahmad A., Margolin, Kim A., Ernstoff, Marc S., Atkins, Michael B., Cohen, Gary I., Whiteside, Theresa L., Butterfield, Lisa H., Kirkwood, John M.
Publicado no J Clin Oncol (2015)

Immune correlates of GM-CSF and melanoma peptide vaccination in a randomized trial for the adjuvant therapy of resected high-risk melanoma (E4697)

Por Butterfield, Lisa H., Zhao, Fengmin, Lee, Sandra, Tarhini, Ahmad A., Margolin, Kim A., White, Richard L., Atkins, Michael B., Cohen, Gary I., Whiteside, Theresa L., Kirkwood, John M., Lawson, David H.
Publicado no Clin Cancer Res (2017)

T cell receptor sequencing of activated CD8 T cells in the blood identifies tumor-infiltrating clones that expand after PD-1 therapy and radiation in a melanoma patient

Por Wieland, Andreas, Kamphorst, Alice O., Adsay, N. Volkan, Masor, Jonathan J., Sarmiento, Juan, Nasti, Tahseen H., Darko, Sam, Douek, Daniel C., Xue, Yue, Curran, Walter J., Lawson, David H., Ahmed, Rafi
Publicado no Cancer Immunol Immunother (2018)